AI assistant
GlaxoSmithKline PLC — Director's Dealing 2016
Jul 12, 2016
5262_dirs_2016-07-12_ab32cd26-a5ca-47e5-8670-22c2f9a52454.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 9962D
GlaxoSmithKline PLC
12 July 2016
GlaxoSmithKline plc (the 'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr S A Hussain
b)
Position/status
President, Global Pharmaceuticals
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each
ISIN: GB0009252882
b)
Nature of the transaction
Acquisition of ordinary shares under the Company's ShareReward Plan
c)
Price(s) and
volume(s)
| Price(s) | Volume(s) |
| £16.7127 | 8 (partnership shares) |
| £16.7127 | 8 (matching shares) |
d)
Aggregated information
Aggregated volume Price
16 Ordinary shares
£16.7127
e)
Date of the transaction
2016-07-11 (12:18 GMT)
f)
Place of the transaction
London Stock Exchange (XLON)
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHQLLFFQDFXBBF
//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'s-twPXuLLDyeDGB-juc75gy07UkiLaPbkLkYu6nkzr_Sn9QrzHowkItR-3OsKVVnFp1pvDWC_tAlAW1UDaAU3UYNtryVO78qdtmYMe0gkTQ1:I9tFx58RHW69Av6jEpPxkBUHtK1_j-zjY4_cGts7ogAd_PzdalHXuHW0reWuSk7S0crFw0Dfh4rSmx0ucrPQ-5apKvuDwqkFX1qg4nySFX81'}});//]]>